𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Haplotype analysis at the low density lipoprotein receptor locus: application to the study of familial hypercholesterolemia in Israel

✍ Scribed by Neville Berkman; Bruce S. Weir; Sigal Pressman-Schwartz; Ayeleth Reshef; Eran Leitersdorf

Publisher
Springer
Year
1992
Tongue
English
Weight
617 KB
Volume
88
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

✦ Synopsis

Familial hypercholesterolemia (FH) results from mutations in the low density lipoprotein (LDL) receptor gene. It has been shown that restriction fragment length polymorphisms (RFLPs) associated with this gene may be used for family and population studies. The present investigation is a population-based study of 19 Jewish families with hypercholesterolemia representing 9 different countries of origin. Ten RFLP sites were used to construct 24 different haplotypes from 112 chromosomes. These haplotypes vary in frequency from 0.9% to 28.6%. Five previously undescribed haplotypes, which comprise 8.1% of the sample, are reported here. The six most common haplotypes account for 70% of the sample. Segregation analysis reveals that, in Israel, distinct LDL receptor haplotypes are associated with hypercholesterolemia in 12 (63%) out of the 19 Jewish families. Five LDL receptor haplotypes co-segregate with hypercholesterolemia. Two of these haplotypes seem to be unique to specific population groups in Israel and may therefore represent founder mutations.

πŸ“œ SIMILAR VOLUMES

Prenatal diagnosis of familial hyperchol
Prenatal diagnosis of familial hypercholesterolemia caused by the β€œLebanese” mutation at the low density lipoprotein receptor locus
✍ Ayeleth Reshef; Vardiella Meiner; Eldad J. Dann; Menachem Granat; Eran Leitersdo πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 369 KB

Here, we report the prenatal diagnosis of familial hypercholesterolemia in a Christian-Arab family that carries the "Lebanese" mutation, a single base substitution that creates a HinfI restriction site, at the low density lipoprotein (LDL) receptor locus. Polymerase chain reaction amplification and

Mutations of the low density lipoprotein
Mutations of the low density lipoprotein receptor in Japanese kindreds with familial hypercholesterolemia
✍ Tohru Funahashi; Yasuko Miyake; Akira Yamamoto; Yuji Matsuzawa; Bun-ichiro Kishi πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 595 KB

Mutations of the low density lipoprotein (LDL) receptor in 16 Japanese kindreds with homozygous familial hypercholesterolemia (FH) were studied using an anti-LDL receptor antibody. The LDL receptor mutations in Japanese FH were heterogeneous and included defects in synthesis, post-translational proc

Three novel partial deletions of the low
Three novel partial deletions of the low-density lipoprotein (LDL) receptor gene in familial hypercholesterolemia
✍ Kimiko Yamakawa; Kohki Takada; Hisako Yanagi; Shigeru Tsuchiya; Koichi Kawai; So πŸ“‚ Article πŸ“… 1989 πŸ› Springer 🌐 English βš– 587 KB

The low-density lipoprotein (LDL) receptor genes from 18 unrelated Japanese heterozygotes and 1 homozygote with classical familial hypercholesterolemia were analyzed by Southern blot hybridization using fragments of the human LDL receptor cDNA as probes. Four different deletion mutations were detect

Two mutations in the same low-density li
Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia
✍ Henrik K. Jensen; Thomas G. Jensen; Ole Faergeman; Lillian G. Jensen; Brage S. A πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

Mutations in genes are not necessarily pathogenic. Expression of mutant genes in cells can therefore be required to demonstrate that mutations in fact disturb protein function. This applies especially to missense mutations, which cause an amino acid to be replaced by another amino acid. In the prese